Sarah Eiser, MD
Obstetrics & Gynecology · Lancaster, PANPI 1598925018
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $52,354 of the $52,814 with a category attached, or 99.1%. Organon accounts for 87.4% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $23,368 and has fallen 73.8% since, to $6,129 in 2025. Among obstetrics & gynecology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 67 payments — averaging $788.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Organon$46K
- Merck$7K
- Coopersurgical, Inc.$51
- Hologic Sales And Service, LLC$39
- Pfizer$17
What the payments were for
- Speaking & faculty fees$52,35499%
- Travel & lodging$3521%
- Food & beverage$900%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Organon | 58 | $46,175 |
| Merck | 5 | $6,531 |
| Coopersurgical, Inc. | 2 | $51 |
| Hologic Sales And Service, LLC | 1 | $39 |
| Pfizer | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEXPLANON$39,000
How this compares
$52,814 in reported general payments places this provider in the 95th percentile of 1,711 obstetrics & gynecology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 12 | $378 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Lancaster
- Kerry-Anne PerkinsLancaster$26K
- Stephen KlaskoPhiladelphia$2.2M
- Stephanie SoberPhiladelphia$1.8M
- Barry JacobsonGlen Mills$302K
- Timothy GrubeFrackville$260K
- Russell StankiewiczLewisburg$202K
- Jamille Nagtalon-RamosPhiladelphia$183K
- Timothy DeimlingMechanicsburg$182K
- Gerald HarkinsMechanicsburg$140K
- Kirthik ParthasarathyWest Reading$103K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.